Perioperative Management
Help Questions
USMLE Step 2 CK › Perioperative Management
A 72-year-old man with hypertension and diabetes is scheduled for elective laparoscopic cholecystectomy. He has exertional chest tightness when walking uphill that resolves with rest; symptoms are unchanged for 6 months. He can climb one flight of stairs but must stop due to chest discomfort.
Physical exam:
- BP 136/80 mm Hg, HR 70
- Normal heart sounds; lungs clear
Pertinent studies:
- ECG: Q waves in V1–V2; no acute changes
- Troponin not obtained
Current medications:
- Metoprolol
- Aspirin
- Atorvastatin
- Metformin
What is the most appropriate preoperative assessment for this patient?
Order transthoracic echocardiogram routinely
Order serial troponins for 24 hours pre-op
Obtain pre-op coronary angiography routinely
Order noninvasive stress testing before surgery
Proceed to surgery without further cardiac testing
Explanation
This question tests USMLE Step 2 CK perioperative management skills, specifically the ability to optimize patients preoperatively and manage perioperative risks. Perioperative management involves evaluating surgical risk, optimizing medical conditions, and planning for potential complications. In this vignette, the patient presents with exertional chest tightness and poor functional capacity, requiring cardiac evaluation before elective surgery. The correct choice, C, is supported by ACC/AHA guidelines for preoperative cardiac risk assessment, addressing the patient's active symptoms and inability to achieve 4 METs. A common distractor, A, fails because it ignores unstable angina symptoms, often due to overreliance on asymptomatic status. Effective teaching strategies include reviewing current guidelines for perioperative care and practicing case scenarios that highlight common pitfalls. Emphasize the importance of individualizing care based on comprehensive risk assessment.
A 67-year-old man is scheduled for elective hip replacement. He has atrial fibrillation on warfarin and a mechanical mitral valve placed 3 years ago. No recent bleeding.
Physical exam:
- BP 126/70 mm Hg, HR 74 irregular
- Mechanical click present
Pertinent labs:
- INR 3.1 today
- Platelets 230k/µL, Cr 1.0 mg/dL
Current medications:
- Warfarin
- Metoprolol
What is the most appropriate strategy for perioperative anticoagulation management?
Hold warfarin 2 days; give oral vitamin K
Hold warfarin 5 days; bridge therapeutic heparin
Continue warfarin; proceed if INR under 3.5
Hold warfarin 5 days; no bridging anticoagulation
Switch warfarin to clopidogrel until after surgery
Explanation
This question tests USMLE Step 2 CK perioperative management skills, specifically the ability to optimize patients preoperatively and manage perioperative risks. Perioperative management involves evaluating surgical risk, optimizing medical conditions, and planning for potential complications. In this vignette, the patient presents with mechanical mitral valve on warfarin, requiring bridging for high thromboembolic risk during elective surgery. The correct choice, C, is supported by ACC/AHA guidelines for mechanical valves, addressing the patient's need for uninterrupted anticoagulation. A common distractor, A, fails because it omits bridging, often due to underestimating embolism risk in prosthetic valves. Effective teaching strategies include reviewing current guidelines for perioperative care and practicing case scenarios that highlight common pitfalls. Emphasize the importance of individualizing care based on comprehensive risk assessment.
A 69-year-old man is scheduled for elective hip replacement. He has atrial fibrillation and takes rivaroxaban. He also takes amiodarone and has normal renal function. The surgeon plans spinal anesthesia.
Physical exam:
- BP 124/72 mm Hg, HR 68 irregular
Pertinent labs:
- Cr 0.9 mg/dL
- Hgb 14.0 g/dL, platelets 200k/µL
Current medications:
- Rivaroxaban 20 mg nightly
- Amiodarone
- Amlodipine
Which medication should be adjusted or discontinued prior to surgery?
Stop rivaroxaban; bridge therapeutic LMWH until surgery
Stop rivaroxaban 12 hours before spinal anesthesia
Switch rivaroxaban to aspirin 48 hours pre-op
Stop rivaroxaban 72 hours before spinal anesthesia
Continue rivaroxaban; perform spinal anesthesia
Explanation
This question tests USMLE Step 2 CK perioperative management skills, specifically the ability to optimize patients preoperatively and manage perioperative risks. Perioperative management involves evaluating surgical risk, optimizing medical conditions, and planning for potential complications. In this vignette, the patient presents with atrial fibrillation on rivaroxaban and amiodarone, requiring extended hold before spinal anesthesia for hip replacement. The correct choice, A, is supported by ASRA guidelines for neuraxial procedures, addressing the patient's risk of spinal hematoma with drug interactions. A common distractor, B, fails because it provides insufficient hold time for high-risk anesthesia, often due to applying standard DOAC intervals. Effective teaching strategies include reviewing current guidelines for perioperative care and practicing case scenarios that highlight common pitfalls. Emphasize the importance of individualizing care based on comprehensive risk assessment.
A 68-year-old man is evaluated in pre-op clinic for elective total hip arthroplasty in 10 days for severe osteoarthritis. He has nonvalvular atrial fibrillation (CHA₂DS₂-VASc 4), hypertension, and stage 3 CKD (baseline Cr 1.6 mg/dL). He reports no prior stroke or systemic embolism. He denies chest pain or dyspnea at rest; he can climb one flight of stairs slowly, limited by hip pain.
History:
- AF diagnosed 4 years ago; no cardioversion history
- No mechanical valves; no rheumatic mitral stenosis
- No recent bleeding; remote peptic ulcer 8 years ago
Physical exam:
- BP 132/76 mm Hg, HR 78 irregularly irregular, SpO₂ 98% RA
- No murmurs; lungs clear; no edema
Pertinent studies:
- Hgb 13.2 g/dL, platelets 210k/µL
- INR 1.1, aPTT normal
- Cr 1.6 mg/dL (eGFR ~42 mL/min/1.73 m²)
- ECG: atrial fibrillation, no ischemic changes
Current medications:
- Apixaban 5 mg BID
- Metoprolol succinate 50 mg daily
- Lisinopril 20 mg daily
- Atorvastatin 40 mg nightly
The orthopedic surgeon anticipates moderate-to-high bleeding risk. Which strategy best manages anticoagulation around surgery?
Continue apixaban through surgery without interruption
Stop apixaban 7 days pre-op, no bridging
Stop apixaban 24 hours pre-op, bridge LMWH
Stop apixaban 48 hours pre-op, no bridging
Stop apixaban 48 hours pre-op, bridge UFH
Explanation
This question tests USMLE Step 2 CK perioperative management skills, specifically the ability to optimize patients preoperatively and manage perioperative risks. Perioperative management involves evaluating surgical risk, optimizing medical conditions, and planning for potential complications. In this vignette, the patient presents with nonvalvular atrial fibrillation on apixaban, stage 3 CKD, and is undergoing elective hip arthroplasty with moderate-to-high bleeding risk, requiring careful anticoagulation interruption without bridging due to moderate thromboembolic risk. The correct choice, B, is supported by ACC/AHA guidelines for perioperative anticoagulation in patients on DOACs, addressing the patient's need for safe drug clearance given reduced renal function. A common distractor, D, fails because it unnecessarily adds bridging with LMWH, often due to overestimation of thromboembolic risk in nonvalvular AF without recent events. Effective teaching strategies include reviewing current guidelines for perioperative care and practicing case scenarios that highlight common pitfalls. Emphasize the importance of individualizing care based on comprehensive risk assessment.
A 76-year-old man with prior MI and stable angina is scheduled for elective abdominal aortic aneurysm repair. He takes metoprolol chronically. On the morning of surgery, a nurse asks whether to administer his beta-blocker.
Physical exam:
- BP 118/68 mm Hg, HR 58
- No wheezes; no signs of decompensated heart failure
Pertinent studies:
- ECG: sinus bradycardia, old inferior infarct
Current medications:
- Metoprolol
- Aspirin
- Atorvastatin
- Isosorbide mononitrate
Which medication should be adjusted or discontinued prior to surgery?
Continue metoprolol through the perioperative period
Give metoprolol only if HR exceeds 100
Hold metoprolol to avoid intraoperative hypotension
Replace metoprolol with clonidine on surgery day
Stop metoprolol 7 days before surgery
Explanation
This question tests USMLE Step 2 CK perioperative management skills, specifically the ability to optimize patients preoperatively and manage perioperative risks. Perioperative management involves evaluating surgical risk, optimizing medical conditions, and planning for potential complications. In this vignette, the patient presents with prior MI on chronic metoprolol, requiring continuation to prevent withdrawal effects during major surgery. The correct choice, B, is supported by ACC/AHA guidelines for perioperative beta-blocker management, addressing the patient's cardiovascular stability. A common distractor, A, fails because it risks rebound tachycardia, often due to fear of bradycardia without evidence of decompensation. Effective teaching strategies include reviewing current guidelines for perioperative care and practicing case scenarios that highlight common pitfalls. Emphasize the importance of individualizing care based on comprehensive risk assessment.
A 62-year-old woman is scheduled for elective laparoscopic cholecystectomy. She has hypertension, type 2 diabetes, and coronary artery disease with a drug-eluting stent placed 5 months ago after NSTEMI. She has been asymptomatic since.
Physical exam:
- BP 126/74 mm Hg, HR 64
- Normal cardiopulmonary exam
Pertinent studies:
- ECG: Q waves in inferior leads, no acute changes
- Troponin: not obtained
Current medications:
- Aspirin 81 mg daily
- Clopidogrel 75 mg daily
- Metoprolol
- Rosuvastatin
- Metformin
What is the best next step in optimizing this patient's medical condition before surgery?
Delay surgery until 6 months post-stent
Proceed; bridge with IV heparin perioperatively
Proceed; stop aspirin and clopidogrel today
Proceed; continue aspirin, stop clopidogrel
Delay surgery until 12 months post-stent
Explanation
This question tests USMLE Step 2 CK perioperative management skills, specifically the ability to optimize patients preoperatively and manage perioperative risks. Perioperative management involves evaluating surgical risk, optimizing medical conditions, and planning for potential complications. In this vignette, the patient presents with recent drug-eluting stent placement 5 months ago and is on DAPT, requiring delay to minimize stent thrombosis risk. The correct choice, D, is supported by ACC/AHA guidelines recommending at least 6 months delay for elective surgery post-DES, addressing the patient's high risk of perioperative cardiac events. A common distractor, B, fails because it risks early stent thrombosis by stopping clopidogrel prematurely, often due to underestimating the optimal DAPT duration. Effective teaching strategies include reviewing current guidelines for perioperative care and practicing case scenarios that highlight common pitfalls. Emphasize the importance of individualizing care based on comprehensive risk assessment.